Australia TGA ARTG recordNLF System - Autologous adipose tissue collection/injection set
Australia TGA ARTG Registered Device · Samson Medical Technologies Pty Ltd · Euromi SA · Class IIa · Started February 23, 2022
Good Name: Samson Medical Technologies Pty Ltd - NLF System - Autologous adipose tissue collection/injection set
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- February 23, 2022
- Effective Date
- February 23, 2022
- Name
- Euromi SA
- Country
- Belgium
- Address
- Zoning Industriel des Plenesses, Avenue des nouvelles technologies, Andrimont, 11 B-4821
The NLF System® is used as part of a liposuction and then an autologous fat lipofilling. In plastic surgery, liposuction coupled to a lipofilling aims to improve the aesthetics of the patient's figure by reducing the volume of fatty tissues in certain areas to increase it in others areas.
Access comprehensive regulatory information for NLF System - Autologous adipose tissue collection/injection set in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Samson Medical Technologies Pty Ltd, manufactured by Euromi SA in Belgium. The device registration started on February 23, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.